NCT00048711View on ClinicalTrials.gov

Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2002

Study Completion Date

June 30, 2006

Conditions
Mucopolysaccharidosis VI
Interventions
DRUG

N-acetylgalactosamine 4-sulfatase

Trial Locations (1)

94949

BioMarin Pharmaceutical Inc., Novato

Sponsors
All Listed Sponsors
lead

BioMarin Pharmaceutical

INDUSTRY